Related references
Note: Only part of the references are listed.Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B
Sakura Kirino et al.
HEPATOLOGY RESEARCH (2023)
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality
Mayu Higuchi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD
Nobuharu Tamaki et al.
NATURE REVIEWS ENDOCRINOLOGY (2022)
Current Trend in Antiviral Therapy for Chronic Hepatitis B
Rong-Nan Chien et al.
VIRUSES-BASEL (2022)
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease
Nobuharu Tamaki et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
Nobuharu Tamaki et al.
HEPATOLOGY RESEARCH (2022)
Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study
Byungyoon Yun et al.
HEPATOLOGY RESEARCH (2022)
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment
Sakura Kirino et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice
Hidenori Toyoda et al.
HEPATOLOGY (2021)
Differential characteristics and outcomes of Asian and non-Asian patients with HBV-related hepatocellular carcinoma
Daniel Q. Huang et al.
LIVER INTERNATIONAL (2021)
Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long-term effects from a prospective study
Satoru Hagiwara et al.
HEPATOLOGY RESEARCH (2021)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige et al.
JOURNAL OF GASTROENTEROLOGY (2021)
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
Nobuharu Tamaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B
Jin Won Chang et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Mindie H. Nguyen et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog
Sakura Kirino et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2020)
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B
Nobuharu Tamaki et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Hepatitis B: Who to treat? A critical review of international guidelines
Daniel Q. Huang et al.
LIVER INTERNATIONAL (2020)
Japan Society of Hepatology Guidelines for the Management of Hepatitis B Virus Infection: 2019 update
Ryoichi Ando et al.
HEPATOLOGY RESEARCH (2020)
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
Hye Won Lee et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B
Lung-Yi Mak et al.
JOURNAL OF HEPATOLOGY (2020)
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Sakura Yamamura et al.
LIVER INTERNATIONAL (2020)
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update
Norihiro Kokudo et al.
HEPATOLOGY RESEARCH (2019)
Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
Noam Peleg et al.
JHEP REPORTS (2019)
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
Lewis R. Roberts et al.
HEPATOLOGY (2018)
Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B
Wai-Kay Seto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
CLINICS IN LIVER DISEASE (2018)
Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method
Nobuharu Tamaki et al.
HEPATOLOGY RESEARCH (2018)
Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens
Nobuharu Tamaki et al.
PLOS ONE (2015)
Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy
Etsuro Orito et al.
HEPATOLOGY RESEARCH (2015)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis
Takashi Kumada et al.
JOURNAL OF HEPATOLOGY (2013)
Diagnostic Accuracy and Reliability of Ultrasonography for the Detection of Fatty Liver: A Meta-Analysis
Ruben Hernaez et al.
HEPATOLOGY (2011)
Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
Masayuki Kurosaki et al.
HEPATOLOGY RESEARCH (2010)
The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation
Masahide Hamaguchi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Share Paper
